Clinical trial
Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent…
NCT00004870 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00004870 |
|---|---|
| Title | Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer |
| Official title | A Phase I/II, Pharmacokinetic, and Biologic Correlative Study of G3139, NSC # 683428 (Phosphorothioate Antisense Oligonucleotide Directed to Bcl-2) and Irinotecan in Patients With Metastatic Colorectal Cancer |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | oblimersen sodium, irinotecan hydrochloride |
| Start date | Jun 1, 2000 |
| Primary completion | Sep 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | Apr 23, 2004 |
| Last update posted | Feb 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: